By adminPosted on April 15, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs At the heart of the licensing deal is CUE-501, a bispecific molecule that can selectively deplete B cells to address autoimmune and inflammatory conditions. Boehringer Ingelheim Boosts I&I Portfolio With $357M in Biobucks for Cue Views: 1 Post navigation Where the Top 100 Firms areJ&J Beats Q1 Analyst Estimates Thanks To Tremfya, Carvykti, While Stelara Fades
